Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prelude Therapeutics (PRLD) Gains from Investment Securities (2023 - 2026)

Prelude Therapeutics' Gains from Investment Securities history spans 4 years, with the latest figure at $583766.0 for Q1 2026.

  • On a quarterly basis, Gains from Investment Securities rose 15027.39% to $583766.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $583766.0, a 15027.39% increase, with the full-year FY2025 number at $14.7 million, up 275.44% from a year prior.
  • Gains from Investment Securities hit $583766.0 in Q1 2026 for Prelude Therapeutics, up from -$39000.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for PRLD hit a ceiling of $15.5 million in Q3 2025 and a floor of -$39000.0 in Q4 2025.
  • Historically, Gains from Investment Securities has averaged $2.8 million across 4 years, with a median of $4072.0 in 2024.
  • The widest YoY moves for Gains from Investment Securities: up 416415.64% in 2025, down 657.14% in 2025.
  • Tracing PRLD's Gains from Investment Securities over 4 years: stood at $11.9 million in 2023, then plummeted by 99.94% to $7000.0 in 2024, then crashed by 657.14% to -$39000.0 in 2025, then skyrocketed by 1596.84% to $583766.0 in 2026.
  • Business Quant data shows Gains from Investment Securities for PRLD at $583766.0 in Q1 2026, -$39000.0 in Q4 2025, and $15.5 million in Q3 2025.